Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Unaudited Standalone Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem has informed BSE that its Board of Directors will meet on Wednesday, 13 August 2025 at 4:30 PM at the registered office. The main agenda is to consider and approve the Unaudited Standalone Financial Results for the quarter ended 30 June 2025 (Q1 FY26). The company has also reminded the stock exchange that the trading window for its shares remains closed till 15 August 2025 for designated persons and their immediate relatives. No financial figures or business details are disclosed in this filing.
This is a routine compliance intimation ahead of the Q1 FY26 results announcement on 13 August. Investors should watch the actual results on that date for any material numbers; the closure of the trading window indicates insiders cannot trade until after the results are declared.